The activist investing giant Elliott Investment Management has bought over a $1 billion stake in BioMarin, a person familiar with the matter tells Endpoints News.
Elliott’s involvement, first reported Tuesday by Reuters, is the latest development for the California drugmaker, which has failed to meet its…
Click here to view original post
